Masebole Masenya to Drug Therapy, Combination
This is a "connection" page, showing publications Masebole Masenya has written about Drug Therapy, Combination.
Connection Strength
0,079
-
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. AIDS. 2019 11 15; 33(14):2197-2203.
Score: 0,040
-
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019 08 29; 381(9):803-815.
Score: 0,039